Didactic migraine education in US doctor of pharmacy programs.
OBJECTIVE
To compare didactic migraine education in doctor of pharmacy (PharmD) programs in the United States with the Headache Consortium's evidence-based migraine treatment recommendations.


METHODS
A self-administered survey instrument was mailed to all 90 Accreditation Council for Pharmacy Education (ACPE) approved PharmD programs in the United States.


RESULTS
Seventy-seven programs responded (86%) and 69 useable survey instruments were analyzed. Fifty-five percent of programs discussed the Consortium's guidelines, 49% discussed the selection of nonprescription versus prescription agents, 45% recommended a butalbital-containing product as migraine treatment, and 20% educated students about tools for assessing migraine-related debilitation. At least 50% of programs taught information consistent with the remaining Consortium recommendations.


CONCLUSIONS
Approximately half of the PharmD programs teach concepts about migraine headache treatment consistent with the US Headache Consortium's recommendations.
Wenzel
Richard G
RG
Diamond Headache Clinic Inpatient Unit, St. Joseph Hospital, Chicago, IL 60657, USA. rich.wenzel@hotmail.com
Padiyara
Rosalyn S
RS
Schommer
Jon C
JC
D003430:Cross-Sectional Studies; D003479:Curriculum / Q000592:standards; D003625:Data Collection / Q000379:methods; D004514:Education, Pharmacy, Graduate / Q000379:methods* / Q000592:standards; D006801:Humans; D008881:Migraine Disorders / Q000628:therapy*; D017410:Practice Guidelines as Topic / Q000592:standards; D014481:United States